MRM-Based Peptide Quantification Service

Overview

MRM-based peptide quantification is a targeted LC-MS/MS approach designed for selective measurement of predefined peptide targets. Specific precursor-product ion transitions are monitored during mass spectrometry analysis, allowing target peptide signals to be measured within complex biological samples with high selectivity. When peptide targets are derived from proteins, these signature peptides can be used as quantitative surrogates for corresponding protein targets.

MRM-based peptide quantification is therefore well suited to focused validation studies in which the targets are already defined and reliable comparison across samples is required.

 

Figure 1. Schematic Diagram of MRM Scanning with Triple Quadrupole Mass Spectrometer

MRM-Based Peptide Quantification Service at MtoZ Biolabs

MtoZ Biolabs provides targeted MRM peptide quantification for selected peptide targets across a range of biological samples.

The service supports relative quantification for comparing target peptide abundance across experimental groups and isotope-standard-based quantification when concentration-level measurements are required. Quantitative strategies are selected according to target information, sample matrix, study design, and analytical objectives.

Projects can be configured for individual targets or focused target panels, providing a practical follow-up strategy for candidate verification, biomarker studies, and other targeted quantitative research.

When This Service Is a Good Fit

MRM-based peptide quantification is particularly suitable when:

• specific peptide or protein targets have already been identified;
• candidates from discovery proteomics require focused quantitative verification;
• selected targets need to be compared consistently across multiple samples;
• biomarker candidates require evaluation in additional sample sets;
• concentration-level peptide measurement is required using appropriate standards.

For projects that begin with broad protein discovery rather than predefined targets, DIA or DDA-based proteomics can be used for candidate screening before subsequent targeted MRM validation.

Analysis Workflow

1. Target Peptide Selection

Target proteins and candidate peptides are evaluated according to sequence information, peptide uniqueness, detectability, and suitability for targeted LC-MS/MS measurement.

2. Sample Preparation and Peptide Generation

Biological samples are processed according to sample type. Protein-based samples undergo protein preparation and enzymatic digestion to generate peptides for targeted analysis.

3. MRM Transition Selection and LC-MS/MS Acquisition

Suitable precursor-product ion transitions are selected and monitored during targeted LC-MS/MS acquisition to obtain quantitative signals for the predefined peptide targets.

4. Quantitative Data Processing

Chromatographic peaks and transition responses are evaluated and integrated for quantitative comparison.

For projects using isotope-labeled peptide standards, calibration strategies can be incorporated to calculate target peptide concentrations.

Sample Submission Requirements

1. Supported Sample Types

MRM peptide quantification can be applied to tissues, cultured cells, biological fluids, protein extracts, purified proteins, and other suitable biological samples containing the targets of interest.

2. Target Information

Target protein identifiers, corresponding amino acid sequences, or predefined peptide information should be provided to support peptide selection and assay development.

3. Sample Amount and Concentration

For protein solution samples:

• Recommended total protein amount: >40 μg
• Recommended protein concentration: >0.5 μg/μL

Final requirements depend on target abundance, sample matrix, target number, and quantitative strategy.

4. Storage and Shipping

Original biological samples should be appropriately frozen and shipped on dry ice. Protein solutions should be prepared under LC-MS/MS-compatible conditions with minimal high-salt or detergent interference.

Applications

1. Biomarker Verification

Quantify selected biomarker candidates identified from discovery studies and evaluate their abundance across independent sample sets.

2. Drug Response Studies

Monitor predefined peptide or protein targets following drug treatment to evaluate molecular responses and treatment-associated changes.

3. Disease Mechanism Research

Measure selected pathway- or disease-associated proteins to investigate targeted molecular changes across biological conditions.

4. Large-Sample Candidate Validation

Apply focused MRM assays across larger sample sets to confirm quantitative trends observed during earlier discovery or screening studies.

Service Advantages

1. High-Selectivity Target Detection

MRM monitors predefined precursor-product ion transitions, supporting selective detection of target peptides in complex biological samples and improving quantitative reliability for low-abundance targets.

2. Multi-Sample Reproducibility

Standardized sample preparation, LC-MS/MS acquisition, and quantitative data processing support consistent measurement across multiple samples and analytical batches.

3. Customized Assay Development

Target peptides and MRM transitions are evaluated according to protein sequence, sample matrix, target abundance, and study objectives, allowing the assay design to be tailored to each project.

4. Integrated Project Support

MtoZ Biolabs supports the targeted quantification workflow from sample preparation and peptide assessment to transition optimization, LC-MS/MS analysis, quantitative data processing, and final result delivery.

Deliverables

1. Target Peptide Information

Selected peptide sequences and associated target information used for quantitative analysis.

2. MRM Transition Information

Precursor-product ion transitions and relevant monitoring information used during targeted LC-MS/MS acquisition.

3. Quantitative Results

Relative peptide abundance results or concentration calculations for projects incorporating isotope-labeled standards and calibration curves.

4. Quality Assessment Results

Chromatographic peak information, transition response assessment, and relevant quantitative quality-control results.

5. Raw Mass Spectrometry Data

Original LC-MS/MS data files generated during targeted acquisition.

6. Final Report

Processed quantitative results, figures, analytical information, and project summary.

FAQ

Q1: How are target peptides selected for MRM quantification?

Target peptide selection considers sequence uniqueness, peptide detectability, digestion characteristics, and suitability for reproducible LC-MS/MS monitoring. Final peptide selection is evaluated according to the target protein and sample matrix.

Q2: Can isotope-labeled peptides be used for concentration measurement?

Yes. Stable isotope-labeled peptide standards can be incorporated with calibration curves for concentration-level peptide quantification. Protein-level interpretation should consider factors such as digestion efficiency and sample preparation.

Q3: When should PRM be considered instead of MRM?

PRM can be considered when high-resolution targeted acquisition or broader fragment-ion information is advantageous. MRM is well suited to predefined transition-based measurement, particularly for focused quantitative assays and repeated analysis across multiple samples.

Q4: How long does an MRM peptide quantification project take?

A typical project requires approximately 3-6 weeks, depending on target peptide selection, method development, standard preparation, sample number, and quantitative requirements.

Contact Us

MRM-based peptide quantification provides a focused LC-MS/MS strategy for validating and quantitatively monitoring predefined peptide targets across biological samples.

Contact MtoZ Biolabs with your target list, sample information, and quantitative objectives to develop an MRM peptide quantification workflow tailored to your study.